Immediate Versus Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device Following Dilation and Evacuation: a Randomized Controlled Trial
Overview
Authors
Affiliations
Background: The study was conducted to compare 6-month usage of the levonorgestrel-releasing intrauterine device (LNG-IUD) when placed immediately or 3 to 6 weeks after dilation and evacuation (D&E) procedure.
Study Design: We enrolled women undergoing D&E at 15 to 23 weeks of gestation. After completion of the D&E, subjects without contraindications to immediate IUD insertion were randomized to immediate or delayed (3 to 6 weeks later) LNG-IUD insertion. Subjects in the immediate group had the LNG-IUD placed using ultrasound guidance. All subjects returned at 3 to 6 weeks and 8 to 10 weeks after D&E and were contacted by phone at 6 months.
Results: Of the 93 subjects enrolled, 88 were randomized. All 44 subjects (100%) randomized to immediate insertion had successful IUD placement, while only 20 (45.5%) of the 44 subjects randomized to delayed insertion returned for IUD placement, all of which were successful [difference 54.5%, 95% confidence interval (CI) 39.8%-69.3%]. Seventeen (38.6%) participants in each group were lost to follow-up. Of subjects contacted at the 6-month follow-up phone call, 23 of 27 women (85.2%) and 17 of 27 women (62.9%) were utilizing the LNG-IUD in the immediate and delayed groups, respectively (difference 22.2%, 95% CI -0.4% to 44.8%). Intrauterine device expulsion occurred in three subjects (6.8%) and one subject (5.0%) in whom the IUD was placed in the immediate and delayed groups, respectively (p=1.0). No significant adverse events occurred.
Conclusion: Significantly more participants had the LNG-IUD placed in the immediate insertion group compared with the delayed insertion group. Given the low risk of complications, immediate post-D&E insertion of the LNG-IUD should be offered, especially for populations that may have difficulty returning for follow-up.
Lou Y, Tang S, Sheng Z, Lian H, Yang J, Jin X Sci Rep. 2024; 14(1):11385.
PMID: 38762680 PMC: 11102502. DOI: 10.1038/s41598-024-62327-1.
Contraception after Abortion and Risk of Repeated Unintended Pregnancy among Health Plan Members.
Postlethwaite D, Lee J, Merchant M, Alabaster A, Raine-Bennett T Perm J. 2018; 22:18-058.
PMID: 30227910 PMC: 6141650. DOI: 10.7812/TPP/18-058.
Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
Goyal V, Canfield C, Aiken A, Dermish A, Potter J Obstet Gynecol. 2017; 129(4):655-662.
PMID: 28277358 PMC: 5364035. DOI: 10.1097/AOG.0000000000001926.
A Dedicated Postpartum Intrauterine Device Inserter: Pilot Experience and Proof of Concept.
Singh S, Das V, Agarwal A, Dewan R, Mittal P, Bhamrah R Glob Health Sci Pract. 2016; 4(1):132-40.
PMID: 27016549 PMC: 4807754. DOI: 10.9745/GHSP-D-15-00355.
Immediate postabortal insertion of intrauterine devices.
Okusanya B, Oduwole O, Effa E Cochrane Database Syst Rev. 2014; (7):CD001777.
PMID: 25101364 PMC: 7079711. DOI: 10.1002/14651858.CD001777.pub4.